These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 16212571)

  • 1. Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment.
    Ficarra G; Beninati F; Rubino I; Vannucchi A; Longo G; Tonelli P; Pini Prato G
    J Clin Periodontol; 2005 Nov; 32(11):1123-8. PubMed ID: 16212571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New therapeutic protocol in the treatment of avascular necrosis of the jaws.
    Agrillo A; Petrucci MT; Tedaldi M; Mustazza MC; Marino SM; Gallucci C; Iannetti G
    J Craniofac Surg; 2006 Nov; 17(6):1080-3. PubMed ID: 17119409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases.
    Dimitrakopoulos I; Magopoulos C; Karakasis D
    Int J Oral Maxillofac Surg; 2006 Jul; 35(7):588-93. PubMed ID: 16687238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteonecrosis of the jaw associated with bisphosphonate use: Presentation of seven cases and literature review.
    Mortensen M; Lawson W; Montazem A
    Laryngoscope; 2007 Jan; 117(1):30-4. PubMed ID: 17202926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between osteonecrosis of the jaws and chronic high-dosage intravenous bisphosphonates therapy.
    Graziani F; Cei S; La Ferla F; Cerri E; Itro A; Gabriele M
    J Craniofac Surg; 2006 Sep; 17(5):876-9. PubMed ID: 17003614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.
    Friedrich RE; Blake FA
    Anticancer Res; 2007; 27(4A):1841-5. PubMed ID: 17649782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
    Grant BT; Amenedo C; Freeman K; Kraut RA
    J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma.
    Diego R; D'Orto O; Pagani D; Agazzi A; Marzano U; Derada Troletti G; Fontanella W; Pignataro L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e1-5. PubMed ID: 17197204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.
    Marx RE; Sawatari Y; Fortin M; Broumand V
    J Oral Maxillofac Surg; 2005 Nov; 63(11):1567-75. PubMed ID: 16243172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteonecrosis of the jaws in patients treated with bisphosphonates. Review of the literature and the Milan experience.
    Oltolina A; Achilli A; Lodi G; Demarosi F; Sardella A
    Minerva Stomatol; 2005; 54(7-8):441-8. PubMed ID: 16211002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonates and osteonecrosis of the jaws: science and rationale.
    Gutta R; Louis PJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):186-93. PubMed ID: 17448709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.
    Bamias A; Kastritis E; Bamia C; Moulopoulos LA; Melakopoulos I; Bozas G; Koutsoukou V; Gika D; Anagnostopoulos A; Papadimitriou C; Terpos E; Dimopoulos MA
    J Clin Oncol; 2005 Dec; 23(34):8580-7. PubMed ID: 16314620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maxilla osseus sequestre and oral exposure: effects of the treatment of multiple myeloma with bisphosphonates.
    Lobato JV; Rodrigues JM; Cavaleiro MV; Lobato JM; Xavier L; Santos JD; Maurício AC
    Acta Med Port; 2007; 20(2):185-92. PubMed ID: 17868526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases.
    Bagan JV; Murillo J; Jimenez Y; Poveda R; Milian MA; Sanchis JM; Silvestre FJ; Scully C
    J Oral Pathol Med; 2005 Feb; 34(2):120-3. PubMed ID: 15641993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis.
    Hansen T; Kunkel M; Weber A; James Kirkpatrick C
    J Oral Pathol Med; 2006 Mar; 35(3):155-60. PubMed ID: 16454811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonates and osteonecrosis of the jaws.
    Mariotti A
    J Dent Educ; 2008 Aug; 72(8):919-29. PubMed ID: 18676801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dental and periodontal history of oncologic patients on parenteral bisphosphonates with or without osteonecrosis of the jaws: a pilot study.
    Carmagnola D; Celestino S; Abati S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Dec; 106(6):e10-5. PubMed ID: 18801674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
    Grewal VS; Fayans EP
    Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates.
    King AE; Umland EM
    Pharmacotherapy; 2008 May; 28(5):667-77. PubMed ID: 18447663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.